Although mTORC2 signalling has been shown to promote HIF-2α accumulation in cancers like renal cell carcinoma54, our results suggest that HIF-2α inhibits mTORC1 signalling in at least the high-grade STS subtypes examined. The gene discussed is EPAS1; the disease is telomere syndrome.